Meeting
2012 ASCO Annual Meeting
The effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: Secondary analysis of RTOG 98-02.
Authors
Roshan Sudhir Prabhu
Winship Cancer Institute, Emory University, Atlanta, GA
Roshan Sudhir Prabhu , Minhee Won , Edward G. Shaw , Meihua Wang , David Brachman , Minesh P. Mehta
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 30, 2012 (suppl; abstr 2047)
DOI
10.1200/jco.2012.30.15_suppl.2047
Abstract #
2047
Poster Bd #
13B
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Clinical characteristics and outcome of a large cohort of patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.
First Author: Audrey-Anne Lamoureux
Poster
2017 Gastrointestinal Cancers Symposium
Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience.
First Author: Jongchan Lee
Poster
2014 ASCO Annual Meeting
PC or PCV? That is the question: A retrospective review of primary anaplastic oligodendroglial tumors treated with procarbazine and CCNU without or with vincristine.
First Author: Courtney C. Webre
Poster
2014 Gastrointestinal Cancers Symposium
A province-wide retrospective comparison of pathologic response and progression-free survival in locally advanced esophagus cancer patients treated with either cisplatin-5FU (CF) or carboplatin-paclitaxel (CP) concurrent with radiation (XRT) with or without surgery.
First Author: Devin Schellenberg